JNJ legal chief Forminard (NYSE: JNJ) exercises 8,921 options, sells 6,226

Rhea-AI Filing Summary

Johnson & Johnson EVP and Chief Legal Officer Elizabeth Forminard reported an option exercise and related share sale. On 02/05/2026, she exercised employee stock options for 8,921 shares of common stock at $129.51 per share.

On the same date, 6,226 common shares coded "F" were sold in market trades at a weighted average price of $237.90, executed in multiple trades between $237.89 and $237.935. After these transactions, she directly held 15,548 shares of Johnson & Johnson common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Forminard Elizabeth

(Last) (First) (Middle)

ONE JOHNSON & JOHNSON PLAZA

(Street)

NEW BRUNSWICK NJ 08933

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/05/2026		M		8,921	A	$129.51	21,774	D
Common Stock	02/05/2026		F		6,226	D	$237.9(1)	15,548	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options (Right to Buy)	$129.51	02/05/2026		M			8,921	02/12/2021(2)	02/11/2028	Common Stock	8,921	$129.51	0	D

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $237.89 to $237.935. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

2. Vested and exercisable on the third anniversary of the date of the grant.

Remarks:

	/s/ Joleen Morgan, as attorney-in-fact for Elizabeth Forminard	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did JNJ EVP Elizabeth Forminard report on this Form 4?

Elizabeth Forminard reported exercising 8,921 employee stock options and acquiring the same number of Johnson & Johnson common shares, then selling 6,226 common shares in market trades. After these transactions, she directly held 15,548 shares of JNJ common stock.

On what date did the reported Johnson & Johnson (JNJ) insider transactions occur?

All reported transactions occurred on February 5, 2026. That day, Elizabeth Forminard exercised 8,921 stock options at $129.51 per share and sold 6,226 common shares in multiple trades, updating her directly owned Johnson & Johnson share balance to 15,548.

How many Johnson & Johnson (JNJ) options did Elizabeth Forminard exercise and at what price?

She exercised 8,921 employee stock options at an exercise price of $129.51 per share. These options, originally granted on February 12, 2021, converted into 8,921 shares of Johnson & Johnson common stock as part of the reported Form 4 transaction.

What sale price was reported for the Johnson & Johnson (JNJ) shares sold by Elizabeth Forminard?

The 6,226 JNJ common shares were sold at a weighted average price of $237.90 per share. The filing notes these were executed in multiple trades, with individual prices ranging from $237.89 to $237.935 during the same trading day.

How many Johnson & Johnson (JNJ) shares does Elizabeth Forminard hold after the Form 4 transactions?

Following the reported option exercise and share sale, Elizabeth Forminard directly holds 15,548 shares of Johnson & Johnson common stock. This balance reflects the 8,921 shares acquired from exercised options and the disposition of 6,226 shares on February 5, 2026.

What is Elizabeth Forminard’s role at Johnson & Johnson (JNJ) according to the Form 4?

The Form 4 identifies Elizabeth Forminard as an officer of Johnson & Johnson, serving as Executive Vice President and Chief Legal Officer. Her insider status requires reporting changes in her beneficial ownership of JNJ securities under Section 16 of U.S. securities laws.